Johnson & Johnson’s $9 Billion Talc Bankruptcy Settlement Under Scrutiny as Trial Concludes
Johnson & Johnson (J&J), a multinational corporation renowned for its healthcare products, has recently concluded a pivotal bankruptcy trial concerning its proposed $9 billion settlement to address thousands of lawsuits alleging that its talc-based products caused cancer. This trial, held in Houston, has significant implications for both the company and the claimants seeking justice. For …